Literature DB >> 13275662

Prevention of experimental tuberculosis with isoniazid.

S H FEREBEE, C E PALMER.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID ISOMERS/effects; TUBERCULOSIS/experimental

Mesh：

Substances：

Year:  1956        PMID： 13275662     DOI： 10.1164/artpd.1956.73.1.1

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  7 in total

1.  [Contribution to the problem of removal of foci in skeletal tuberculous diseases].

Authors:  K BERNDL; O ERHART
Journal:  Arch Orthop Unfallchir       Date:  1962

2.  Tuberculin sensitivity of young adults in the United States.

Authors:  L B EDWARDS; E F KROHN; N E MANOS; C E PALMER
Journal:  Public Health Rep       Date:  1956-07       Impact factor: 2.792

3.  Prevention of tuberculosis.

Authors:  F HEAF
Journal:  Br Med J       Date:  1956-12-15

Review 4.  Treatment of Latent Tuberculosis Infection-An Update.

Authors:  Moises A Huaman; Timothy R Sterling
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

5.  Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.

Authors:  Nyanda Elias Ntinginya; Lindsey Te Brake; Philip C Hill; Reinout van Crevel; Issa Sabi; Nyasatu Chamba; Kajiru Kilonzo; Sweetness Laizer; Irene Andia-Biraro; Davis Kibirige; Andrew Peter Kyazze; Sandra Ninsiima; Julia A Critchley; Renee Romeo; Josephine van de Maat; Willyhelmina Olomi; Lucy Mrema; David Magombola; Issakwisa Habakkuk Mwayula; Katrina Sharples
Journal:  Trials       Date:  2022-06-10       Impact factor: 2.728

6.  Isoniazid chemoprophylaxis of tuberculosis.

Authors:  D Jenkins; F F Davidson
Journal:  Calif Med       Date:  1972-04

7.  Management of latent tuberculosis infections in australia and new zealand: a review of current practice.

Authors:  Justin T Denholm; Emma S McBryde
Journal:  Tuberc Res Treat       Date:  2010-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.